{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:13:13Z","timestamp":1777493593007,"version":"3.51.4"},"reference-count":61,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To investigate child and parental characteristics of medication use for attention-deficit\/hyperactivity disorder (ADHD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Participants were part of the prospective population-based Norwegian Mother, Father and Child Cohort study (MoBa) (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009114,500 children, 95,000 mothers, and 75,000 fathers). This cohort was linked to the Norwegian Prescription Database (NorPD) and the Norwegian Patient Registry (NPR) to compare child and parental characteristics in children medicated and not medicated for ADHD during years 2008\u20132013.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One thousand seven hundred and sixty-four children (74% boys) with ADHD (International Classification of Diseases [ICD-10]: F90 and F98.8) were identified. One thousand three hundred and sixty-two (77%) used medication. Boys and girls did not differ in the use of ADHD medication (both 77%). Mean age at first prescription was 9 years in both boys and girls, and age at ADHD diagnosis was 8 years in medicated and unmedicated children. Significantly more hyperkinetic conduct disorders (F90.1), and significantly fewer with attention-deficit disorder (F98.8) were found among the medicated children compared to the unmedicated children. The medicated children also had a significantly lower global functioning (Child Global Assessment Scale). Child disruptive symptoms reported in the MoBa child age 3 year questionnaire were significantly higher in children who used medication compared to the nonusers (\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      \u2009=\u20092.2,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.03), and group differences in ADHD symptoms at age 3 years were close to significant (\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      \u2009=\u20091.8,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.07). Other preschool child and parental characteristics were not significantly different in the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this large birth cohort study, where a great majority of children with ADHD used medication, only child characteristics were significantly associated with the use of medication. We could not replicate previous findings suggesting that \u201cenvironmental factors,\u201d such as parental education and psychopathology, drive medication use. The small differences between medicated and unmedicated children in this cohort study, where a majority used medication, might be due to strong established clinical practices where medication is offered as a treatment option, particularly for hyperkinetic conduct disorder in an egalitarian high-income society.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2019.0019","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T11:41:28Z","timestamp":1594899688000},"page":"456-464","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Child and Parental Characteristics of Medication Use for Attention-Deficit\/Hyperactivity Disorder"],"prefix":"10.1177","volume":"30","author":[{"given":"Beate","family":"Oerbeck","sequence":"first","affiliation":[{"name":"Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Furu","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases &amp; Ageing, Centre of Fertility &amp; Health, Norwegian Institute of Public Health, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Zeiner","sequence":"additional","affiliation":[{"name":"Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Aase","sequence":"additional","affiliation":[{"name":"Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Reichborn-Kjennerud","sequence":"additional","affiliation":[{"name":"Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway."},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Are Hugo","family":"Pripp","sequence":"additional","affiliation":[{"name":"Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin Romvig","family":"Overgaard","sequence":"additional","affiliation":[{"name":"Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"Achenbach TM Rescorla L: Manual for the ASEBA preschool forms & profiles: child behavior checklist for ages 1 1\/2\u20135 language development survey caregiver\u2014Teacher report form: an integrated system of multi-informant assessment. ASEBA Burlington 2000."},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington DC American Psychiatric Association 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_4_1","unstructured":"Anderson J: Reported Diagnosis and Prescription Utilization Related to Attention Deficit Hyperactivity Disorder in Children Ages 5\u201317 2008\u20132015. Statistical Brief #514. Rockville MD Agency for Healthcare Research and Quality 2018."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-006-0549-0"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e318179963c"},{"key":"e_1_3_4_7_1","unstructured":"Bricker D Squires J: Ages and Stages Questionnaires: A Parent-Completed Child Monitoring System. Baltimore MD Brooks Publishing Co. 1999."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-017-1061-4"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12825"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa4901_13"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2018.0095"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054709347173"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12724"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00494.x"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.141952"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0022"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10578-017-0737-9"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.62.5.pss6205_0459"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2009.01638.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.64.5.847"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291704002892"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-018-1106-3"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.8.896"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsm023"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796011000564"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0064"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.02.006"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.4.754"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw029"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl170"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2008.01.009"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370404901107"},{"key":"e_1_3_4_34_1","unstructured":"MoBa The Norwegian Mother and Child Cohort Study: The Norwegian Mother and Child Cohort Study End of Enrolment\u2014Protocol II Revised October 2012. Available at: www.fhi.no\/moba-en (accessed July8 2020)."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-018-1211-3"},{"key":"e_1_3_4_36_1","unstructured":"National Institute for Health and Care Excellence: Attention deficit hyperactivity disorder: diagnosis and management [NG87]. 2018. Available at: https:\/\/www.nice.org.uk\/guidance\/ng87 (accessed July8 2020)."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2009.01062.x"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-006-1003-z"},{"key":"e_1_3_4_39_1","first-page":"23","article-title":"ADHD, comorbid disorders and psychosocial functioning: How representative is a child cohort study?","volume":"17","author":"Oerbeck B","year":"2017","unstructured":"Oerbeck B, , Overgaard KR, , Aspenes ST, , Pripp AH, , Mordre M, , Aase H, , Reichborn-Kjennerud T, , Zeiner P: ADHD, comorbid disorders and psychosocial functioning: How representative is a child cohort study?. Findings from a national patient registry. BMC Psychiatry, 17:23, 2017a.","journal-title":"Findings from a national patient registry. BMC Psychiatry"},{"key":"e_1_3_4_40_1","doi-asserted-by":"crossref","unstructured":"Oerbeck B Overgaard KR Pripp AH Reichborn-Kjennerud T Aase H Zeiner P: Early predictors of ADHD: Evidence from a prospective birth cohort. J Atten Disord 1087054717696765 2017b.","DOI":"10.1177\/1087054717696765"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/17439760701756946"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12381"},{"key":"e_1_3_4_43_1","first-page":"42","article-title":"The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: A systematic review and meta-analysis","volume":"60","author":"Pringsheim T","year":"2015","unstructured":"Pringsheim T, , Hirsch L, , Gardner D, , Gorman DA: The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: A systematic review and meta-analysis. Part 1: Psychostimulants, alpha-2 agonists, and atomoxetine. Can J Psychiatry, 60:42\u201351, 2015.","journal-title":"Part 1: Psychostimulants, alpha-2 agonists, and atomoxetine. Can J Psychiatry"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30293-1"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.05.028"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-013-0681-3"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.5324\/nje.v24i1-2.1821"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(17)30167-0"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054718816172"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790100074010"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0033"},{"key":"e_1_3_4_52_1","first-page":"893","article-title":"Can medication effects be determined using national registry data?","volume":"80","author":"Sonuga-Barke EJ","year":"2016","unstructured":"Sonuga-Barke EJ: Can medication effects be determined using national registry data?. A cautionary reflection on risk of bias in \u201cBig Data\u201d analytics. Biol Psychiatry, 80:893\u2013895, 2016.","journal-title":"A cautionary reflection on risk of bias in \u201cBig Data\u201d analytics. Biol Psychiatry"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039480310000932"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-2654"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00238-X"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1990.tb01564.x"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0000000000000170"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K143"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30096-3"},{"key":"e_1_3_4_60_1","unstructured":"World Health Organization (WHO): International Classification of Diseases and Related Health Problems (ICD-10). 10th ed. Geneva World Health Organization 1990."},{"key":"e_1_3_4_61_1","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO): Multiaxial Classification of Child and Adolescent Psychiatric Disorders. Cambridge Cambridge University Press 1996.","DOI":"10.1017\/CBO9780511983757"},{"key":"e_1_3_4_62_1","unstructured":"World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology: ATC Classification Index with DDDs 2017. Oslo Norway Norwegian Institute for Public Health 2016."}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2019.0019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2019.0019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2019.0019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:55:50Z","timestamp":1777388150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2019.0019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1089\/cap.2019.0019"],"URL":"https:\/\/doi.org\/10.1089\/cap.2019.0019","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}